Clinical Characteristics and Prognosis of Biliary Atresia with Low Serum Matrix Metalloproteinase-7 Levels
Topic overview
This study examines biliary atresia patients with unexpectedly low serum MMP-7 levels, investigating why this diagnostic biomarker fails to elevate in certain cases. Understanding these atypical presentations helps clinicians avoid missed diagnoses when relying on MMP-7 screening for differentiating BA from other causes of infant cholestasis.
Key takeaways
- Serum MMP-7 is a reliable biomarker to distinguish biliary atresia from other causes of neonatal cholestasis.
- A subset of BA patients present with normal or only slightly elevated MMP-7 levels, creating diagnostic challenges.
- Low MMP-7 in confirmed BA cases may correlate with distinct clinical phenotypes or disease severity patterns.
- Clinicians should not exclude BA diagnosis based solely on low MMP-7; additional workup remains essential.
- Understanding MMP-7 variability in BA can improve risk stratification and prognostic counseling for families.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Clinical Characteristics and Prognosis of Biliary Atresia with Low Serum Matrix Metalloproteinase-7 Levels. GlobalCastMD Medical Library. 2023-12-02. https://library.globalcastmd.com/article/8290
Comments